Voglinice-GM 2mg/500mg/0.2mg Tablet
Manufacturer
Unimac Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg)
Key Information
Short Description
Voglinice-GM 2mg/500mg/0.2mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Dosage Form
Tablet
Introduction
Voglinice-GM 2mg/500mg/0.2mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Voglinice-GM 2mg/500mg/0.2mg Tablet is to be taken empty stomach.
Safety Information
Side Effects
No common side effects listed.
Alcohol Warning
It is unsafe to consume alcohol with Voglinice-GM 2mg/500mg/0.2mg Tablet.
Breastfeeding Warning
Voglinice-GM 2mg/500mg/0.2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy Warning
Voglinice-GM 2mg/500mg/0.2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Voglinice-GM 2mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines:
Quick Tips
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Related Medicines
Vogli-GM 2 Tablet
Gemer V2 Tablet
Voziglim VM 2mg/500mg/0.2mg Tablet
Nuvogli Trio 2mg Tablet
Tri Vobimeal 2mg/500mg/0.2mg Tablet
Glimevog M 2 Tablet
Glimeon MV 2mg/500mg/0.2mg Tablet
Triglisim 2mg/500mg/0.2mg Tablet
Triglymet 2mg/500mg/0.2mg Tablet
Glimigen-MV2 Tablet
Frequently asked questions
What is Voglinice-GM 2mg/500mg/0.2mg Tablet?
Voglinice-GM 2mg/500mg/0.2mg Tablet is a combination of Glimepiride, Metformin, and Voglibose for the treatment of Type 2 Diabetes Mellitus (DM).
What are the possible side effects of Voglinice-GM 2mg/500mg/0.2mg Tablet?
Common side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Are there any specific conditions in which Voglinice-GM 2mg/500mg/0.2mg Tablet should not be taken?
Patients with known allergy to the components or excipients of this medication, moderate to severe kidney disease, inflammatory bowel diseases, colonic ulcerations, and underlying metabolic acidosis (including diabetic ketoacidosis) should avoid taking this medicine.
Is it safe to take alcohol while I am also taking Voglinice-GM 2mg/500mg/0.2mg Tablet?
No, consuming alcohol with Voglinice-GM 2mg/500mg/0.2mg Tablet is not advisable as it may lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Can the use of Voglinice-GM 2mg/500mg/0.2mg Tablet cause hypoglycemia?
Yes, this medication can cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It is more likely to occur when missing meals, drinking alcohol, over-exercising, or taking other antidiabetic medications simultaneously. Regular blood sugar monitoring is essential.
What are the instructions for the storage and disposal of Voglinice-GM 2mg/500mg/0.2mg Tablet?
Keep this medication in its original packaging, tightly closed. Store according to the provided instructions on the package label. Dispose of unused medicine properly by ensuring it is not accessible to pets, children, or other individuals.
